← Leaderboards
Pamela Vivian Tran
Brigham And Women'S Hospital
$4,737,119
Attributed
$5,163,369
Total exposure
7
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $656.8K · FY2010–24$1M$750K$500K$250K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$5,163,369 · 7
By mechanism
R01$1,764,431 · 1
R21$1,278,613 · 3
P20$1,124,572 · 1
U54$995,753 · 2
Top collaborators
- Irfan Saadi4 shared
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Duncan Maru$2,347,640
Others in their field
Top investigators on “Mouse Model”
- Dennis R. Burton · Scripps Research Institute$280,661,242
- David Heimbrook · Leidos Biomedical Research, Inc.$84,491,283
- Kc Kent Lloyd · University Of California At Davis$74,285,556
- Alan F Horwitz · University Of Virginia Charlottesville$73,668,592
- Stanley B Prusiner · University Of California San Francisco$61,905,394
- Ed Lein · Allen Institute$59,425,748
Research focus
Mouse ModelInsightCellsGenesKidneyMutant Strains MiceMutationDesignEtiologyAllelesMediatingMolecularPhenotypeCiliaSignal PathwayExperimental StudyErinaceidaeDefectExhibitsIn VivoHuman DiseaseCystAffectCell Model
Grant awards (21)
Investigating the protective effect of maternal Thm1 heterozygosity against cleft palate$193,750
R21 · FY2024 · DE
In utero rescue of cleft palate using maternal administration of folic acid$193,750
R21 · FY2024 · DE
Biomedical Research Core 2 - Rodent Models & Drug Testing Core$174,335
U54 · FY2024 · DK · contact PI
In utero rescue of cleft palate using maternal administration of folic acid$232,500
R21 · FY2023 · DE
Investigating the protective effect of maternal Thm1 heterozygosity against cleft palate$232,500
R21 · FY2023 · DE
Biomedical Research Core 2 - Rodent Models & Drug Testing Core$191,828
U54 · FY2023 · DK · contact PI
Biomedical Research Core 2 - Rodent Models & Drug Testing Core$190,317
U54 · FY2022 · DK · contact PI
Biomedical Research Core 2 - Rodent Models & Drug Testing Core$208,684
U54 · FY2021 · DK · contact PI
Biomedical Research Core 2 - Rodent Models & Drug Testing Core$230,589
U54 · FY2020 · DK · contact PI
Hedgehog signaling as a therapeutic target for cystic kidney disease$348,755
R01 · FY2019 · DK · contact PI
Hedgehog signaling as a therapeutic target for cystic kidney disease$348,755
R01 · FY2018 · DK · contact PI
Hedgehog signaling as a therapeutic target for cystic kidney disease$369,411
R01 · FY2017 · DK · contact PI
Hedgehog signaling as a therapeutic target for cystic kidney disease$348,755
R01 · FY2016 · DK · contact PI
Molecular Mechanism of THM1-Medicated Renal Cystogenesis$226,500
P20 · FY2016 · GM · contact PI
Hedgehog signaling as a therapeutic target for cystic kidney disease$348,755
R01 · FY2015 · DK · contact PI
Molecular Mechanism of THM1-Medicated Renal Cystogenesis$226,500
P20 · FY2015 · GM · contact PI
Molecular Mechanism of THM1-Medicated Renal Cystogenesis$226,500
P20 · FY2014 · GM · contact PI
Molecular Mechanism of THM1-Medicated Renal Cystogenesis$218,572
P20 · FY2013 · GM · contact PI
Molecular Mechanism of THM1-Medicated Renal Cystogenesis$226,500
P20 · FY2012 · GM · contact PI
THM1 modulation of GLI2 activation in cystic kidney disease$176,663
R21 · FY2011 · DK · contact PI
THM1 modulation of GLI2 activation in cystic kidney disease$249,450
R21 · FY2010 · DK · contact PI